1340: ZYNs | Skeptical Sunday

1340: ZYNs | Skeptical Sunday

From The Jordan Harbinger Show by Jordan Harbinger

June 7, 2026 · 1h 2m · Episode 1340

About this episode

Nick Pell discusses the complexities and health implications of ZYNs, a popular nicotine pouch.

Are ZYNs gas-station Ozempic or a dopamine loan shark? Nick Pell digs into the nicotine pouch boom this Skeptical Sunday — and the verdict is messy. Welcome to Skeptical Sunday, a special edition of The Jordan Harbinger Show where Jordan and a guest break down a topic that you may have never thought about, open things up, and debunk common misconceptions. This time around, we’re joined by writer and researcher Nick Pell ! Full show notes and resources can be found here: jordanharbinger.com/1340 On This Week's Skeptical Sunday: ZYNs are a tobacco-free nicotine pouch born from Swedish "snus." Swedish Match engineers extracted nicotine salts and loaded them into food-grade fillers, creating a shelf-stable white pouch that doesn't stain teeth or require spitting. Philip Morris bought the company for $16 billion in 2022. The harm-reduction case is strong, but "less harmful" isn't "harmless." ZYNs skip the carbon monoxide, tar, and lung damage of cigarettes, and carry roughly 90 — 99% lower carcinogens. But they still raise heart rate and blood pressure, can cause gum recession, disrupt sleep, and remain wildly addictive. The user base skews young, male, and white. Men are 88% of the…

People in this episode

Host: Jordan Harbinger

Guest: Nick Pell

Topics covered

  • nicotine pouches
  • harm reduction
  • addiction
  • youth trends
  • health risks

Keywords

  • ZYNs
  • nicotine
  • pouches
  • addiction
  • health risks
  • youth
  • harm reduction

Mentioned in this episode

Organizations: Philip Morris, Swedish Match

Products: ZYNs

Places: Sweden

More episodes of The Jordan Harbinger Show

Explore listener stats, chart rankings, contacts and more on the The Jordan Harbinger Show podcast page.